Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Tenax Therapeutics (TENX) Short-term Investments (2016 - 2017)

Historic Short-term Investments for Tenax Therapeutics (TENX) over the last 3 years, with Q3 2017 value amounting to $6.8 million.

  • Tenax Therapeutics' Short-term Investments rose 21.59% to $6.8 million in Q3 2017 from the same period last year, while for Sep 2017 it was $6.8 million, marking a year-over-year increase of 21.59%. This contributed to the annual value of $3.3 million for FY2016, which is N/A changed from last year.
  • As of Q3 2017, Tenax Therapeutics' Short-term Investments stood at $6.8 million, which was up 21.59% from $6.6 million recorded in Q2 2017.
  • In the past 5 years, Tenax Therapeutics' Short-term Investments registered a high of $16.5 million during Q4 2015, and its lowest value of $3.3 million during Q4 2016.
  • Its 3-year average for Short-term Investments is $7.6 million, with a median of $6.8 million in 2016.
  • Per our database at Business Quant, Tenax Therapeutics' Short-term Investments tumbled by 8012.76% in 2016 and then grew by 21.59% in 2017.
  • Over the past 3 years, Tenax Therapeutics' Short-term Investments (Quarter) stood at $16.5 million in 2015, then tumbled by 80.13% to $3.3 million in 2016, then skyrocketed by 106.13% to $6.8 million in 2017.
  • Its Short-term Investments was $6.8 million in Q3 2017, compared to $6.6 million in Q2 2017 and $5.5 million in Q1 2017.